Four weeks later, levels of IL-6, IP-10, MCP-1, VEGF and PDGF-AA were decreased in the eyes that received triamcinolone, whereas only VEGF levels were lower in eyes that received bevacizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback